Funding

Epoch Biodesign Secures $12M To Scale Recycled Nylon Production

Mar 25, 2026 | By Kailee Rainse

Epoch Biodesign, a London-based company developing enzymatic recycling technology, has raised $12 million in a strategic funding round, bringing total funding to over $50 million.

SUMMARY

  • Epoch Biodesign, a London-based company developing enzymatic recycling technology, has raised $12 million in a strategic funding round, bringing total funding to over $50 million.

The round included participation from lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif, and other investors.

Epoch is advancing material circularity by enabling the recycling of nylon 6,6 without using virgin feedstock. Its process breaks down waste garments and other nylon-based materials into their original chemical components, such as adipic acid and HMDA which can then be reused to produce new, virgin-quality polymers and yarn.

Read Also - Barcelona’s Galtea Secures €2.7M From Mozilla Ventures To Boost AI Evaluation Platform

Epoch Biodesign’s technology can process complex materials, including blended textiles, coated fibres, and mixed plastics, tackling waste streams that are typically hard to recycle.

By partnering with existing yarn producers, Epoch provides a drop-in solution for brands and manufacturers to enhance supply chain sustainability without changing suppliers.

The new funding will support global commercialisation and strengthen partnerships across industries, including apparel and automotive.

About Epoch Biodesign

Epoch Biodesign uses AI-designed enzymes to enable circular recycling of hard-to-recycle plastics and textiles at low temperatures. Their biorecycling platform produces sustainable materials for apparel, automotive, packaging and more, helping brands and industries close the loop and embrace a new era of material circularity.

Recommended Stories for You